Skip to main content

Robotic Flight Simulator Surgery Market Technology Scope , Industry Share and Global Trends

The global robotic flight simulator surgery market will gain significant accruals by 2023, registering a CAGR of 11.6% throughout the forecast period (2017 to 2023). Robotic flight simulator surgery, just like a flight simulator for pilots, offers training tools that can address the need for a realistic training environment for robot-assisted surgery.
Robot-assisted surgeries are trending everywhere wherein surgical robots are used to carry out various procedures. Surgeries performed with the help of surgical robots has many benefits such as reduced blood loss, reduced complications, reduced pain, and improved accuracy.
These simulators leverage the early learning curve of robot-assisted surgery that can shorten procedures without jeopardizing the safety and welfare of patients. Equipped with hi-tech solutions these simulators offer sufficient opportunities to surgeons that they have not had outside of the operating room.
Also, these surgeries require a shorter hospital stay which is not only good for the patients but also financially it’s good for a country’s health services. With the advancement of technologies, the prices of surgical robots are falling rapidly. Soon, each & every surgery will be performed using surgical robots.
Many of the Market Vendors to improve their performance, and when it comes to expansion, they acquire promising companies in the rapidly growing markets. Technology providers, employing a continuous improvement strategy invest heavily to implement improvements and to develop new technologies to meet the consumers changing needs. Following are Some of the Key players leading the global robotic flight simulator surgery market include –
TransEnterix (U.S.)
Intuitive Surgical (U.S.)
Titan Medical (Canada)
AVRA (U.S.)
Virtualincision (U.S.)
Hansen Medical (U.S.)
Interventional Systems (U.S.)
Corindus Vascular Robots (U.S.)
Stryker (U.S.)
Mazor Robotics (Israel)
and among others
A robotic surgical system affords all the features that an experienced surgeon needs to ensure equivalent or superior outcomes to conventional surgery. However, Robot-assisted surgeries demand extensive training for surgeons to be able to operate with the help of a robotic assistant. Thus, training remains vital to develop some proficiency before surgeons start doing robotic surgeries on their own.
Global Industry Segmentations:
For ease of understanding, the market has been segmented into four key dynamics: –
The global robotic flight simulator surgery market is segmented on the basis of application, method, and end-user.
On the basis of application, the market is segmented into general surgery, cardiology surgery, neurosurgery, gynaecology, and others.
On the basis of method, the market is segmented into direct tele-manipulator and computer control.
On the basis of end-user, the market is segmented into hospitals, clinics, ambulatory surgical centres, and others.
LIST OF TABLES
Table 1 Global Robotic Flight Simulator Surgery Market Industry Synopsis, 2017–2023
Table 2 Global Robotic Flight Simulator Surgery Market Estimates & Forecast, 2017–2023, (USD Million)
Table 3 Global Robotic Flight Simulator Surgery Market, by Region, 2017–2023, (USD Million)
Table 4 Global Robotic Flight Simulator Surgery Market, by Application, 2017–2023, (USD Million)
Table 5 Global Robotic Flight Simulator Surgery Market, by Method, 2017–2023, (USD Million)
Table 6 Global Robotic Flight Simulator Surgery Market, by End-User, 2017–2023, (USD Million
…To be Continued.
Regional Analysis: Geographically, the Americas is expected to dominate the global market owing to the rising prevalence of neurological diseases, presence of developed healthcare infrastructure, and high disposable income. Europe is anticipated to hold the second largest position in the global stereotactic surgery devices market. The market growth in this region is mainly due to the increasing occurrences of brain diseases and presence of developed healthcare sector. The Asia-Pacific region is expected to be fastest growing region owing to the growing prevalence of brain-related diseases and continuously growing healthcare sector. The Middle East & Africa has the least share of the market owing to the limited presence of developed healthcare infrastructure in the African region.
About Market Research Future: Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
 

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...

Middle East And Africa Pediatric Healthcare Market Development Research with Forthcoming Opportunities and Challenges

  Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Avail a Free Sample@  https://www.marketresearchfuture.com/...